Intrommune Therapeutics

Intrommune Therapeutics

Verified
New york-based biotechnology company .

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$800k—1m (Dealroom.co estimates Jun 2018.)
New York City New York (HQ)
Authorizing premium user...